Loading…

Comparison of the Effects of Citicoline and Piracetam on Hypoxic-ischemic Brain Damage in Neonatal Rabbits

Perinatal hypoxic-ischemic brain injuries have been a major cause of mortality and neurodevelopmental morbidities in newborns. Citicoline and Piracetam have been used as nootropic agents in a number of studies. In this investigation, we aimed to determine the effects of these agents solely and in co...

Full description

Saved in:
Bibliographic Details
Published in:Iranian journal of child neurology 2022, Vol.16 (1), p.77-84
Main Authors: Ebrahimi, Sedigheh, Ashkani Esfahani, Soheil, Ebrahimi, Alireza
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 84
container_issue 1
container_start_page 77
container_title Iranian journal of child neurology
container_volume 16
creator Ebrahimi, Sedigheh
Ashkani Esfahani, Soheil
Ebrahimi, Alireza
description Perinatal hypoxic-ischemic brain injuries have been a major cause of mortality and neurodevelopmental morbidities in newborns. Citicoline and Piracetam have been used as nootropic agents in a number of studies. In this investigation, we aimed to determine the effects of these agents solely and in combination in hypoxic-ischemic brain damage in rabbit neonates. Hypoxic-ischemic brain damage was induced by the occlusion of both uterine arteries of dams for eight minutes. The subjects were randomly divided into five groups as follows (n=6 per group): control group without hypoxia (C1), control group with hypoxic-ischemic damage (C2), the third group (P) received Piracetam (100 mg/kg), the fourth group (T) administered with Citicoline (250 mg/kg), and the fifth (PT) received both. The preventive effects of the two drugs on hypoxic-ischemic brain damage were microscopically investigated by the rates of damage to the hippocampus. Neuronal destruction rates in C1, C2, P, T, and PT were 4%, 45%, 37.5%, 12.5% (P=0.01 vs. C2), and 20% (P=0.03 vs. C2), respectively. The total means of hypoxic-ischemic damage, cell edema, neuronal degeneration, and eosinophilic degeneration were lower in the T group compared to C2 (P
doi_str_mv 10.22037/ijcn.v15i4.29816
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8753006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2620408395</sourcerecordid><originalsourceid>FETCH-LOGICAL-p224t-32c3868c4e3218ac9a303a4a596b0ccd9fb5106d10cbdcb942acc875b891a2af3</originalsourceid><addsrcrecordid>eNpdkdFLHDEQxoNU9LD-AX2RgC992XOSbHLJi9CethZEpbTPy2w26-XYTbabnOh_b0pV2s7LzDA_Pr6PIeQDgyXnIFZnfmvD8oFJXy-50UztkQUH0BWsAN6RBVsJWdVK6UNynNIWSgnBNPADcigk51xJsyDbdRwnnH2Kgcae5o2jl33vbE6_17XP3sbBB0cxdPTOz2hdxpEW-uppio_eVj7ZjRu9pZ9n9IFe4Ij3jpbpxsWAGQf6HdvW5_Se7Pc4JHf80o_Izy-XP9ZX1fXt12_rT9fVxHmdK8Gt0Erb2gnONFqDAgTWKI1qwdrO9K1koDoGtu1sa2qO1uqVbLVhyLEXR-T8j-60a0fXWRfyjEMzzX7E-amJ6Jt_L8Fvmvv40BQRAaCKwMcXgTn-2rmUm7GEdMOAwcVdargStQQjBC_o6X_oNu7mUOIVikMNWhhZqJO_Hb1ZeX2DeAZ8A4y2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2620408395</pqid></control><display><type>article</type><title>Comparison of the Effects of Citicoline and Piracetam on Hypoxic-ischemic Brain Damage in Neonatal Rabbits</title><source>PubMed Central</source><creator>Ebrahimi, Sedigheh ; Ashkani Esfahani, Soheil ; Ebrahimi, Alireza</creator><creatorcontrib>Ebrahimi, Sedigheh ; Ashkani Esfahani, Soheil ; Ebrahimi, Alireza</creatorcontrib><description>Perinatal hypoxic-ischemic brain injuries have been a major cause of mortality and neurodevelopmental morbidities in newborns. Citicoline and Piracetam have been used as nootropic agents in a number of studies. In this investigation, we aimed to determine the effects of these agents solely and in combination in hypoxic-ischemic brain damage in rabbit neonates. Hypoxic-ischemic brain damage was induced by the occlusion of both uterine arteries of dams for eight minutes. The subjects were randomly divided into five groups as follows (n=6 per group): control group without hypoxia (C1), control group with hypoxic-ischemic damage (C2), the third group (P) received Piracetam (100 mg/kg), the fourth group (T) administered with Citicoline (250 mg/kg), and the fifth (PT) received both. The preventive effects of the two drugs on hypoxic-ischemic brain damage were microscopically investigated by the rates of damage to the hippocampus. Neuronal destruction rates in C1, C2, P, T, and PT were 4%, 45%, 37.5%, 12.5% (P=0.01 vs. C2), and 20% (P=0.03 vs. C2), respectively. The total means of hypoxic-ischemic damage, cell edema, neuronal degeneration, and eosinophilic degeneration were lower in the T group compared to C2 (P&lt;0.05). According to our results and previous findings, Citicoline as a treatment for hypoxic-ischemic brain injuries could be beneficial, and it has priority over neuroprotective agents like Piracetam. Moreover, the combination of Citicoline and Piracetam showed no superior effect in contrast with Citicoline alone. However, experimental studies on larger populations and clinical trials are highly suggested.</description><identifier>ISSN: 1735-4668</identifier><identifier>EISSN: 2008-0700</identifier><identifier>DOI: 10.22037/ijcn.v15i4.29816</identifier><identifier>PMID: 35222659</identifier><language>eng</language><publisher>Iran: Iranian Child Neurology Society</publisher><subject>Arteries ; Brain damage ; Brain injury ; Cerebral blood flow ; Citicoline ; Clinical trials ; Edema ; Hypoxia ; Ischemia ; Leukocytes (eosinophilic) ; Neonates ; Neurodegeneration ; Neuroprotection ; Neuroprotective agents ; Nootropic agents ; Original ; Piracetam ; Population studies ; Traumatic brain injury ; Uterus</subject><ispartof>Iranian journal of child neurology, 2022, Vol.16 (1), p.77-84</ispartof><rights>Copyright Iranian Child Neurology Society Winter 2022</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753006/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753006/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35222659$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ebrahimi, Sedigheh</creatorcontrib><creatorcontrib>Ashkani Esfahani, Soheil</creatorcontrib><creatorcontrib>Ebrahimi, Alireza</creatorcontrib><title>Comparison of the Effects of Citicoline and Piracetam on Hypoxic-ischemic Brain Damage in Neonatal Rabbits</title><title>Iranian journal of child neurology</title><addtitle>Iran J Child Neurol</addtitle><description>Perinatal hypoxic-ischemic brain injuries have been a major cause of mortality and neurodevelopmental morbidities in newborns. Citicoline and Piracetam have been used as nootropic agents in a number of studies. In this investigation, we aimed to determine the effects of these agents solely and in combination in hypoxic-ischemic brain damage in rabbit neonates. Hypoxic-ischemic brain damage was induced by the occlusion of both uterine arteries of dams for eight minutes. The subjects were randomly divided into five groups as follows (n=6 per group): control group without hypoxia (C1), control group with hypoxic-ischemic damage (C2), the third group (P) received Piracetam (100 mg/kg), the fourth group (T) administered with Citicoline (250 mg/kg), and the fifth (PT) received both. The preventive effects of the two drugs on hypoxic-ischemic brain damage were microscopically investigated by the rates of damage to the hippocampus. Neuronal destruction rates in C1, C2, P, T, and PT were 4%, 45%, 37.5%, 12.5% (P=0.01 vs. C2), and 20% (P=0.03 vs. C2), respectively. The total means of hypoxic-ischemic damage, cell edema, neuronal degeneration, and eosinophilic degeneration were lower in the T group compared to C2 (P&lt;0.05). According to our results and previous findings, Citicoline as a treatment for hypoxic-ischemic brain injuries could be beneficial, and it has priority over neuroprotective agents like Piracetam. Moreover, the combination of Citicoline and Piracetam showed no superior effect in contrast with Citicoline alone. However, experimental studies on larger populations and clinical trials are highly suggested.</description><subject>Arteries</subject><subject>Brain damage</subject><subject>Brain injury</subject><subject>Cerebral blood flow</subject><subject>Citicoline</subject><subject>Clinical trials</subject><subject>Edema</subject><subject>Hypoxia</subject><subject>Ischemia</subject><subject>Leukocytes (eosinophilic)</subject><subject>Neonates</subject><subject>Neurodegeneration</subject><subject>Neuroprotection</subject><subject>Neuroprotective agents</subject><subject>Nootropic agents</subject><subject>Original</subject><subject>Piracetam</subject><subject>Population studies</subject><subject>Traumatic brain injury</subject><subject>Uterus</subject><issn>1735-4668</issn><issn>2008-0700</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpdkdFLHDEQxoNU9LD-AX2RgC992XOSbHLJi9CethZEpbTPy2w26-XYTbabnOh_b0pV2s7LzDA_Pr6PIeQDgyXnIFZnfmvD8oFJXy-50UztkQUH0BWsAN6RBVsJWdVK6UNynNIWSgnBNPADcigk51xJsyDbdRwnnH2Kgcae5o2jl33vbE6_17XP3sbBB0cxdPTOz2hdxpEW-uppio_eVj7ZjRu9pZ9n9IFe4Ij3jpbpxsWAGQf6HdvW5_Se7Pc4JHf80o_Izy-XP9ZX1fXt12_rT9fVxHmdK8Gt0Erb2gnONFqDAgTWKI1qwdrO9K1koDoGtu1sa2qO1uqVbLVhyLEXR-T8j-60a0fXWRfyjEMzzX7E-amJ6Jt_L8Fvmvv40BQRAaCKwMcXgTn-2rmUm7GEdMOAwcVdargStQQjBC_o6X_oNu7mUOIVikMNWhhZqJO_Hb1ZeX2DeAZ8A4y2</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Ebrahimi, Sedigheh</creator><creator>Ashkani Esfahani, Soheil</creator><creator>Ebrahimi, Alireza</creator><general>Iranian Child Neurology Society</general><general>Shahid Beheshti University of Medical Sciences</general><scope>NPM</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2022</creationdate><title>Comparison of the Effects of Citicoline and Piracetam on Hypoxic-ischemic Brain Damage in Neonatal Rabbits</title><author>Ebrahimi, Sedigheh ; Ashkani Esfahani, Soheil ; Ebrahimi, Alireza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p224t-32c3868c4e3218ac9a303a4a596b0ccd9fb5106d10cbdcb942acc875b891a2af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Arteries</topic><topic>Brain damage</topic><topic>Brain injury</topic><topic>Cerebral blood flow</topic><topic>Citicoline</topic><topic>Clinical trials</topic><topic>Edema</topic><topic>Hypoxia</topic><topic>Ischemia</topic><topic>Leukocytes (eosinophilic)</topic><topic>Neonates</topic><topic>Neurodegeneration</topic><topic>Neuroprotection</topic><topic>Neuroprotective agents</topic><topic>Nootropic agents</topic><topic>Original</topic><topic>Piracetam</topic><topic>Population studies</topic><topic>Traumatic brain injury</topic><topic>Uterus</topic><toplevel>online_resources</toplevel><creatorcontrib>Ebrahimi, Sedigheh</creatorcontrib><creatorcontrib>Ashkani Esfahani, Soheil</creatorcontrib><creatorcontrib>Ebrahimi, Alireza</creatorcontrib><collection>PubMed</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Iranian journal of child neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ebrahimi, Sedigheh</au><au>Ashkani Esfahani, Soheil</au><au>Ebrahimi, Alireza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the Effects of Citicoline and Piracetam on Hypoxic-ischemic Brain Damage in Neonatal Rabbits</atitle><jtitle>Iranian journal of child neurology</jtitle><addtitle>Iran J Child Neurol</addtitle><date>2022</date><risdate>2022</risdate><volume>16</volume><issue>1</issue><spage>77</spage><epage>84</epage><pages>77-84</pages><issn>1735-4668</issn><eissn>2008-0700</eissn><abstract>Perinatal hypoxic-ischemic brain injuries have been a major cause of mortality and neurodevelopmental morbidities in newborns. Citicoline and Piracetam have been used as nootropic agents in a number of studies. In this investigation, we aimed to determine the effects of these agents solely and in combination in hypoxic-ischemic brain damage in rabbit neonates. Hypoxic-ischemic brain damage was induced by the occlusion of both uterine arteries of dams for eight minutes. The subjects were randomly divided into five groups as follows (n=6 per group): control group without hypoxia (C1), control group with hypoxic-ischemic damage (C2), the third group (P) received Piracetam (100 mg/kg), the fourth group (T) administered with Citicoline (250 mg/kg), and the fifth (PT) received both. The preventive effects of the two drugs on hypoxic-ischemic brain damage were microscopically investigated by the rates of damage to the hippocampus. Neuronal destruction rates in C1, C2, P, T, and PT were 4%, 45%, 37.5%, 12.5% (P=0.01 vs. C2), and 20% (P=0.03 vs. C2), respectively. The total means of hypoxic-ischemic damage, cell edema, neuronal degeneration, and eosinophilic degeneration were lower in the T group compared to C2 (P&lt;0.05). According to our results and previous findings, Citicoline as a treatment for hypoxic-ischemic brain injuries could be beneficial, and it has priority over neuroprotective agents like Piracetam. Moreover, the combination of Citicoline and Piracetam showed no superior effect in contrast with Citicoline alone. However, experimental studies on larger populations and clinical trials are highly suggested.</abstract><cop>Iran</cop><pub>Iranian Child Neurology Society</pub><pmid>35222659</pmid><doi>10.22037/ijcn.v15i4.29816</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1735-4668
ispartof Iranian journal of child neurology, 2022, Vol.16 (1), p.77-84
issn 1735-4668
2008-0700
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8753006
source PubMed Central
subjects Arteries
Brain damage
Brain injury
Cerebral blood flow
Citicoline
Clinical trials
Edema
Hypoxia
Ischemia
Leukocytes (eosinophilic)
Neonates
Neurodegeneration
Neuroprotection
Neuroprotective agents
Nootropic agents
Original
Piracetam
Population studies
Traumatic brain injury
Uterus
title Comparison of the Effects of Citicoline and Piracetam on Hypoxic-ischemic Brain Damage in Neonatal Rabbits
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T16%3A24%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20Effects%20of%20Citicoline%20and%20Piracetam%20on%20Hypoxic-ischemic%20Brain%20Damage%20in%20Neonatal%20Rabbits&rft.jtitle=Iranian%20journal%20of%20child%20neurology&rft.au=Ebrahimi,%20Sedigheh&rft.date=2022&rft.volume=16&rft.issue=1&rft.spage=77&rft.epage=84&rft.pages=77-84&rft.issn=1735-4668&rft.eissn=2008-0700&rft_id=info:doi/10.22037/ijcn.v15i4.29816&rft_dat=%3Cproquest_pubme%3E2620408395%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p224t-32c3868c4e3218ac9a303a4a596b0ccd9fb5106d10cbdcb942acc875b891a2af3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2620408395&rft_id=info:pmid/35222659&rfr_iscdi=true